536 related articles for article (PubMed ID: 22699311)
1. Regulation of the metastatic cell phenotype by sialylated glycans.
Schultz MJ; Swindall AF; Bellis SL
Cancer Metastasis Rev; 2012 Dec; 31(3-4):501-18. PubMed ID: 22699311
[TBL] [Abstract][Full Text] [Related]
2. Significance of β-Galactoside α2,6 Sialyltranferase 1 in Cancers.
Lu J; Gu J
Molecules; 2015 Apr; 20(5):7509-27. PubMed ID: 25919275
[TBL] [Abstract][Full Text] [Related]
3. Tumor cell N-glycans in metastasis.
Laidler P; Lityńska A
Acta Biochim Pol; 1997; 44(2):343-57. PubMed ID: 9360725
[TBL] [Abstract][Full Text] [Related]
4. Sialylated N-glycans in adult rat brain tissue--a widespread distribution of disialylated antennae in complex and hybrid structures.
Zamze S; Harvey DJ; Chen YJ; Guile GR; Dwek RA; Wing DR
Eur J Biochem; 1998 Nov; 258(1):243-70. PubMed ID: 9851715
[TBL] [Abstract][Full Text] [Related]
5. Sialylated β1, 6 branched N-glycans modulate the adhesion, invasion and metastasis of hepatocarcinoma cells.
Yu X; Zhao Y; Wang L; Chen X; Su Z; Zhang H; Yuan Q; Wang S
Biomed Pharmacother; 2016 Dec; 84():1654-1661. PubMed ID: 27847205
[TBL] [Abstract][Full Text] [Related]
6. An immunohistochemical employer monoclonal antibodies against Le(a), sialyl Le(a), Le(x), and sialyl Le(x) antigens in primary colorectal, carcinomas and lymph node and hepatic lesions.
Nakagoe T; Fukushima K; Hirota M; Kusano H; Ayabe H; Tomita M; Kamihira S
J Gastroenterol; 1994 Apr; 29(2):129-38. PubMed ID: 7912139
[TBL] [Abstract][Full Text] [Related]
7. Glycomic analysis of gastric carcinoma cells discloses glycans as modulators of RON receptor tyrosine kinase activation in cancer.
Mereiter S; Magalhães A; Adamczyk B; Jin C; Almeida A; Drici L; Ibáñez-Vea M; Gomes C; Ferreira JA; Afonso LP; Santos LL; Larsen MR; Kolarich D; Karlsson NG; Reis CA
Biochim Biophys Acta; 2016 Aug; 1860(8):1795-808. PubMed ID: 26721331
[TBL] [Abstract][Full Text] [Related]
8. Role of tumor cell sialylation in pancreatic cancer progression.
Marciel MP; Haldar B; Hwang J; Bhalerao N; Bellis SL
Adv Cancer Res; 2023; 157():123-155. PubMed ID: 36725107
[TBL] [Abstract][Full Text] [Related]
9. Integrated Transcriptomics, Proteomics, and Glycomics Reveals the Association between Up-regulation of Sialylated N-glycans/Integrin and Breast Cancer Brain Metastasis.
Peng W; Zhu R; Zhou S; Mirzaei P; Mechref Y
Sci Rep; 2019 Nov; 9(1):17361. PubMed ID: 31758065
[TBL] [Abstract][Full Text] [Related]
10. Sialyl Lewis(a): a tumor-associated carbohydrate antigen involved in adhesion and metastatic potential of cancer cells.
Ugorski M; Laskowska A
Acta Biochim Pol; 2002; 49(2):303-11. PubMed ID: 12362971
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal Stromal Cells Regulate Sialylations of N-Glycans, Affecting Cell Migration and Survival.
Templeton K; Ramos M; Rose J; Le B; Zhou Q; Cressman A; Ferreyra S; Lebrilla CB; Fierro FA
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34206740
[TBL] [Abstract][Full Text] [Related]
12. Rho GTPase Rac1: molecular switch within the galectin network and for N-glycan α2,6-sialylation/O-glycan core 1 sialylation in colon cancer in vitro.
André S; Singh T; Lacal JC; Smetana K; Gabius HJ
Folia Biol (Praha); 2014; 60(3):95-107. PubMed ID: 25056432
[TBL] [Abstract][Full Text] [Related]
13. Glycosylation: a hallmark of cancer?
Vajaria BN; Patel PS
Glycoconj J; 2017 Apr; 34(2):147-156. PubMed ID: 27975160
[TBL] [Abstract][Full Text] [Related]
14. Sialylation: an Avenue to Target Cancer Cells.
Vajaria BN; Patel KR; Begum R; Patel PS
Pathol Oncol Res; 2016 Jul; 22(3):443-7. PubMed ID: 26685886
[TBL] [Abstract][Full Text] [Related]
15. Cancer snap-shots: Biochemistry and glycopathology of O-glycans: A review.
Sanji AS; J M; Gurav MJ; Batra SK; Chachadi VB
Int J Biol Macromol; 2024 Mar; 260(Pt 1):129318. PubMed ID: 38232866
[TBL] [Abstract][Full Text] [Related]
16. Cell surface glycan-lectin interactions in tumor metastasis.
Rambaruth ND; Dwek MV
Acta Histochem; 2011 Oct; 113(6):591-600. PubMed ID: 21501858
[TBL] [Abstract][Full Text] [Related]
17. Increased alpha2,6 sialylation of N-glycans in a transgenic mouse model of hepatocellular carcinoma.
Pousset D; Piller V; Bureaud N; Monsigny M; Piller F
Cancer Res; 1997 Oct; 57(19):4249-56. PubMed ID: 9331085
[TBL] [Abstract][Full Text] [Related]
18. Dynamic Sialylation in Transforming Growth Factor-β (TGF-β)-induced Epithelial to Mesenchymal Transition.
Du J; Hong S; Dong L; Cheng B; Lin L; Zhao B; Chen YG; Chen X
J Biol Chem; 2015 May; 290(19):12000-13. PubMed ID: 25809486
[TBL] [Abstract][Full Text] [Related]
19. Aberrant glycosylation of αvβ3 integrin is associated with melanoma progression.
Pocheć E; Bubka M; Rydlewska M; Janik M; Pokrywka M; Lityńska A
Anticancer Res; 2015 Apr; 35(4):2093-103. PubMed ID: 25862865
[TBL] [Abstract][Full Text] [Related]
20. N-glycans modulate K(v)1.5 gating but have no effect on K(v)1.4 gating.
Schwetz TA; Norring SA; Bennett ES
Biochim Biophys Acta; 2010 Mar; 1798(3):367-75. PubMed ID: 19961828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
